JP Morgan Chase’s Psyence Biomedical PBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$60 Buy
+11
New +$45 ﹤0.01% 7884
2024
Q4
– Hold
0
– – – 7780
2024
Q3
– Hold
0
– – – 7725
2024
Q2
– Hold
0
– – – 7299
2024
Q1
– Hold
0
– – – 7319

Other funds holding PBM

JP Morgan Chase's PBM Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Psyence Biomedical (PBM) in Q3 2026: 11 shares worth $60. The stake represents ﹤0.01% of the portfolio and ranks #7884 among its holdings.

10 funds tracked by Wall St. Rank hold PBM as of Q3 2026.

  • JP Morgan Chase held 11 shares of Psyence Biomedical worth $60 as of Q3 2026.
  • Psyence Biomedical was a new JP Morgan Chase position in Q3 2026.
  • Psyence Biomedical made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7884 holding.
  • 10 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.